Early detection of changes in phospholipid metabolism during neoadjuvant chemotherapy in breast cancer patients using phosphorus magnetic resonance spectroscopy at 7T
Authors:
Open Access
- 29 March 2019
- journal article
- research article
- Published by Wiley in NMR in Biomedicine
- Vol. 32 (6) , e4086
Abstract
The purpose of this work was to investigate whether noninvasive early detection (after the first cycle) of response to neoadjuvant chemotherapy (NAC) in breast cancer patients was possible. 31P‐MRSI at 7 T was used to determine different phosphor metabolites ratios and correlate this to pathological response.31P‐MRSI was performed in 12 breast cancer patients treated with NAC. 31P spectra were fitted and aligned to the frequency of phosphoethanolamine (PE). Metabolic signal ratios for phosphomonoesters/phosphodiesters (PME/PDE), phosphocholine/glycerophosphatidylcholine (PC/GPtC), phosphoethanolamine/glycerophosphoethanolamine (PE/GPE) and phosphomonoesters/in‐organic phosphate (PME/Pi) were determined from spectral fitting of the individual spectra and the summed spectra before and after the first cycle of NAC. Metabolic ratios were subsequently related to pathological response. Additionally, the correlation between the measured metabolic ratios and Ki‐67 levels was determined using linear regression.Four patients had a pathological complete response after treatment, five patients a partial pathological response, and three patients did not respond to NAC. In the summed spectrum after the first cycle of NAC, PME/Pi and PME/PDE decreased by 18 and 13%, respectively. A subtle difference among the different response groups was observed in PME/PDE, where the nonresponders showed an increase and the partial and complete responders a decrease (P = 0.32). No significant changes in metabolic ratios were found. However, a significant association between PE/Pi and the Ki‐67 index was found (P = 0.03).We demonstrated that it is possible to detect subtle changes in 31P metabolites with a 7 T MR system after the first cycle of NAC treatment in breast cancer patients. Nonresponders showed different changes in metabolic ratios compared with partial and complete responders, in particular for PME/PDE; however, more patients need to be included to investigate its clinical value.Keywords
Funding Information
- KWF Kankerbestrijding (Alpe d'Huzes project nr: UU 2013‐6302)
- Nederlandse Organisatie voor Wetenschappelijk Onderzoek (VENI grant: 016.148.002)
This publication has 45 references indexed in Scilit:
- Adiabatic multi‐echo 31P spectroscopic imaging (AMESING) at 7 T for the measurement of transverse relaxation times and regaining of sensitivity in tissues with short T2* valuesNMR in Biomedicine, 2013
- On shimming approaches in 3T breast MRIMagnetic Resonance in Medicine, 2012
- Prognostic value of metabolic response in breast cancer patients receiving neoadjuvant chemotherapyBMC Cancer, 2012
- Choline metabolism in malignant transformationNature Reviews Cancer, 2011
- Assessment of Ki67 in Breast Cancer: Recommendations from the International Ki67 in Breast Cancer Working GroupJNCI: Journal of the National Cancer Institute, 2011
- 31P MRSI and 1H MRS at 7 T: initial results in human breast cancerNMR in Biomedicine, 2011
- Distinct choline metabolic profiles are associated with differences in gene expression for basal-like and luminal-like breast cancer xenograft modelsBMC Cancer, 2010
- Changes in neuronal activation patterns in response to androgen deprivation therapy: a pilot studyBMC Cancer, 2010
- Multivariate Modeling and Prediction of Breast Cancer Prognostic Factors Using MR MetabolomicsJournal of Proteome Research, 2009
- Ki-67 immunostaining in 322 primary breast cancers: Associations with clinical and pathological variables and prognosisInternational Journal of Cancer, 1997